Epidemiology of drug–resistant tuberculosis in Hunan China over a 10–year period

Yi Liu, Jue Wang, Xiaojie Wan, Wang Peng, Jingwei Guo, Xi Yang, Di Zhou, Wenbin Li, Jie Duan, Xuan Zeng, Hua Bai, Zhenhua Chen, Fanyan Luo, Yunhong TanFrontiers in Public Health 2026 · DOI

Abstract

This study presents a 10-year epidemiological assessment of drug-resistant tuberculosis (DR-TB) in Hunan Province, China, covering 2014-2023. A disproportionately high burden was observed among middle-aged and older male farmers. The predominance of isoniazid-resistant (INH-R) TB and multidrug-resistant (MDR) TB, together with distinct regional and demographic risk profiles, underscores an urgent need to strengthen TB control measures. These results support the implementation of targeted interventions, including intensified screening in high-risk populations and high-incidence areas, along with optimized treatment regimens, to curb the ongoing DR-TB epidemic in South-Central China.

Introduction

Tuberculosis (TB) remains a formidable global health challenge, with the emergence of drug-resistant strains (DR-TB) significantly complicating treatment and control efforts. China, as one of the countries with the highest TB burdens globally, faces a critical need for localized epidemiological data to inform public health strategies. Hunan Province, located in South-Central China, represents a region where long-term data on DR-TB resistance patterns and demographic risks have historically been scarce. This study maps the "landscape of resistance" over a decade (2014–2023), identifying key subtypes including single drug-resistant (SDR-TB), poly-drug-resistant (PDR-TB), multidrug-resistant (MDR-TB), rifampicin-resistant (RR-TB), and isoniazid-resistant (INH-R TB).

Methods

This research involved a retrospective analysis of 6,597 laboratory-confirmed DR-TB cases recorded at the Hunan Chest Hospital, a provincial-level designated TB institute, between January 1, 2014, and August 1, 2023. All isolates underwent phenotypic drug susceptibility testing (DST) using the absolute concentration method on Löwenstein–Jensen medium, the gold standard for determining antibiotic efficacy. Statistical analysis, including multivariable logistic regression to calculate adjusted odds ratios (ORs), was performed to isolate specific risk factors such as age, sex, and geographic region while controlling for confounding variables.

Results and Discussion

Demographic Vulnerabilities

The study revealed a significant demographic skew in DR-TB prevalence. A disproportionate burden was observed among males, who were represented at a 3:1 ratio compared to females. The highest incidence was found in the 50–59 age group, accounting for 24.78% of cases. Notably, occupational data highlighted a severe vulnerability among farmers, who comprised 64.44% of the total cases.

Occupational distribution of DR-TB cases in Hunan, showing a predominant burden among farmers (64.44%).

This "farmer vulnerability" likely stems from a combination of physically demanding labor, lower health literacy, and limited access to consistent healthcare in rural areas, which can lead to interrupted treatment—a primary driver of acquired drug resistance.

Geographic Distribution and Hotspots

Resistance patterns were not uniformly distributed across the province. Spatial analysis identified three cities—Changsha, Shaoyang, and Loudi—as major hotspots, accounting for nearly 40% of all recorded cases.

Geographic distribution of DR-TB cases across Hunan Province, highlighting high-incidence regions like Changsha and Shaoyang.

The western region of Hunan exhibited the highest risk for multidrug-resistant TB (MDR-TB) with an OR of 1.734. In contrast, the more developed eastern region showed higher risks for simpler resistance types (SDR and PDR), possibly due to more robust screening infrastructure that detects cases before they progress to complex resistance patterns.

The most common resistance subtypes identified were INH-R TB (56.27%) and MDR-TB (52.37%). Detection of MDR-TB peaked in 2018, likely reflecting the selective pressure exerted by the widespread use of rifampicin and isoniazid as first-line treatments. Interestingly, female patients were found to have a significantly lower risk for MDR-TB (OR = 0.819) and RR-TB (OR = 0.784) compared to males, suggesting potential biological or behavioral protective factors.

Conclusion and Future Directions

The 10-year data from Hunan underscores an urgent need for targeted rural health interventions, particularly focusing on middle-aged male farmers. While this study provides a comprehensive provincial overview, it is limited by its single-center nature and the lack of genotyping data to distinguish between acquired and transmitted resistance. Future research should incorporate multicenter studies and Whole-Genome Sequencing (WGS) to track the transmission dynamics of resistant strains in real-time, enabling more precise public health responses.

Summary updated

Abstract

This study presents a 10-year epidemiological assessment of DR-TB in Hunan Province, China, covering 2014-2023. A disproportionately high burden was observed among middle-aged and older male farmers. The predominance of INH-R TB and MDR-TB, together with distinct regional and demographic risk profiles, underscores an urgent need to strengthen TB control measures. These results support the implementation of targeted interventions, including intensified screening in high-risk populations and in high-incidence areas, along with optimized treatment regimens, to curb the ongoing DR-TB epidemic in South-Central China.
BibTeX
@inproceedings{liu2026epidemiology,
  author = {Yi Liu and Jue Wang and Xiaojie Wan and Wang Peng and Jingwei Guo and Xi Yang and Di Zhou and Wenbin Li and Jie Duan and Xuan Zeng and Hua Bai and Zhenhua Chen and Fanyan Luo and Yunhong Tan},
  title = {{Epidemiology of drug–resistant tuberculosis in Hunan China over a 10–year period}},
  booktitle = {Frontiers in Public Health},
  year = {2026},
  doi = {10.3389/fpubh.2026.1771140},
}
Figure